Zacks analyst Grant Zeng was out pounding the table on Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG), reiterating an Outperform rating and a $10.
Zacks analyst Grant Zeng was out pounding the table on Arrowhead Research Corp. (NASDAQ:ARWR), reiterating an Outperform rating and a $15 price target, which represents a …
BHP Billiton Limited (NYSE:BHP) was once riding high as commodities boomed but now that China’s economy is slowing and commodity prices have plunged, …
Expedia, Inc. (NASDAQ:EXPE) is perfectly positioned to capture the surge in travel that is expected in 2015 as consumers have more money in …
On Oct 3, 2014, Zacks Investment Research upgraded Apple Inc. (NASDAQ:AAPL) to a Zacks Rank #1 (Strong Buy).
